Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Two demyelinating diseases in the brain of a single patient, PML and MS: how to minimize 'one' while treating the 'other'.

Major EO, Douek DC, Frohman EM, Walsh DR.

Expert Rev Clin Immunol. 2013 Oct;9(10):887-90. doi: 10.1586/1744666X.2013.841559. No abstract available.

PMID:
24128152
2.

Monoclonal antibodies and progressive multifocal leukoencephalopathy.

Berger JR, Houff SA, Major EO.

MAbs. 2009 Nov-Dec;1(6):583-9.

3.

Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host.

Hou J, Major EO.

J Neurovirol. 2000 May;6 Suppl 2:S98-S100. Review.

PMID:
10871795
4.

Immunosuppression increases latent infection of brain by JC polyomavirus.

Bayliss J, Karasoulos T, Bowden S, Glogowski I, McLean CA.

Pathology. 2011 Jun;43(4):362-7. doi: 10.1097/PAT.0b013e3283463558.

PMID:
21532525
6.

Reply to "'Thinking without thinking' about natalizumab and PML".

Houff S, Berger JR.

J Neurol Sci. 2008 Jan 15;264(1-2):198-9; author reply 199. Epub 2007 Oct 15. No abstract available.

PMID:
17936798
7.

Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.

Bellizzi A, Nardis C, Anzivino E, Rodìo D, Fioriti D, Mischitelli M, Chiarini F, Pietropaolo V.

J Neurovirol. 2012 Feb;18(1):1-11. doi: 10.1007/s13365-012-0080-7. Review.

PMID:
22290500
8.

Immunosuppression increases JC polyomavirus large T antigen DNA load in the brains of patients without progressive multifocal leukoencephalopathy.

Bayliss J, Karasoulos T, McLean CA.

J Infect Dis. 2013 Jan 1;207(1):133-6. doi: 10.1093/infdis/jis668. Epub 2012 Oct 30.

PMID:
23112281
9.

Polyomavirus JC in the context of immunosuppression: a series of adaptive, DNA replication-driven recombination events in the development of progressive multifocal leukoencephalopathy.

Johnson EM, Wortman MJ, Dagdanova AV, Lundberg PS, Daniel DC.

Clin Dev Immunol. 2013;2013:197807. doi: 10.1155/2013/197807. Epub 2013 Apr 15. Review.

10.

Reactivation of JC virus and development of PML in patients with multiple sclerosis.

Khalili K, White MK, Lublin F, Ferrante P, Berger JR.

Neurology. 2007 Mar 27;68(13):985-90. Review.

PMID:
17389301
11.

Atypical PML leading to a diagnosis of common variable immunodeficiency.

Snyder MD, Storch GA, Clifford DB.

Neurology. 2005 May 10;64(9):1661. No abstract available.

PMID:
15883345
12.
13.

Does anti-JCV therapy improve the prognosis of AIDS-related PML?

Mikita K, Maeda T, Fujikura Y, Kozaki Y, Hara Y, Kanoh S, Kishida S, Saijo M, Nakamichi K, Kawana A.

Clin Neurol Neurosurg. 2013 Sep;115(9):1853-4. doi: 10.1016/j.clineuro.2013.01.013. Epub 2013 Mar 5. No abstract available.

PMID:
23481900
15.

A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

Du Pasquier RA, Kuroda MJ, Zheng Y, Jean-Jacques J, Letvin NL, Koralnik IJ.

Brain. 2004 Sep;127(Pt 9):1970-8. Epub 2004 Jun 23.

PMID:
15215217
16.

[Progressive multifocal leukoencephalopathy].

Pál E, Aschermann Z, Gömöri E, Kovács GG, Simon G, Maródi L, Komoly S, Illés Z.

Ideggyogy Sz. 2007 May 30;60(5-6):263-8. Hungarian.

PMID:
17578275
17.

A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.

Lee P, Plavina T, Castro A, Berman M, Jaiswal D, Rivas S, Schlain B, Subramanyam M.

J Clin Virol. 2013 Jun;57(2):141-6. doi: 10.1016/j.jcv.2013.02.002. Epub 2013 Mar 5.

PMID:
23465394
18.

History and current concepts in the pathogenesis of PML.

Major EO.

Cleve Clin J Med. 2011 Nov;78 Suppl 2:S3-7. doi: 10.3949/ccjm.78.s2.02.

19.

[Neuropathology of progressive multifocal leukoencephalopathy].

Murayama S, Saito Y.

No To Shinkei. 2007 Feb;59(2):119-24. Review. Japanese.

PMID:
17315753
20.

Supplemental Content

Support Center